fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride recall (Wells Pharma of Houston LLC)
DrugClass IIOngoing
Summary: Wells Pharma of Houston LLC is recalling fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.. Reason: cGMP deviations.
What is being recalled
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Why
cGMP deviations.
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
U.S. Nationwide.
How to tell if yours is affected
Lot 020226202150202, Exp Date 05/05/2026.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0508-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | April 1, 2026 |
| Reported | May 6, 2026 |
| Company | Wells Pharma of Houston LLC |
| Company location | Houston, TX, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 50 syringes |
More recalls from Wells Pharma of Houston LLC · all drug recalls · recalls from April 2026